Navigation Links
Spanish Fabry disease patients appear to react differently to the rest of Europe
Date:7/20/2011

Spanish patients with Fabry disease, a rare hereditary condition where abnormal fatty deposits collect in blood vessels and organs throughout the body, appear to react differently to those in other European countries, according to a study in the August issue of IJCP, the International Journal of Clinical Practice.

Researchers from three university hospitals say that the Spanish patients showed a different pattern of organ involvement in ill health and death to other European patients on the Fabry Outcome Survey (FOS).

Reporting the findings of more than 30 investigators from the Spanish FOS study group, they add that their study reinforces the need for rare disease registers like the FOS, so that clinicians and researchers can share information on conditions that are relatively uncommon.

"The FOS was initiated in 2001 to gain further understanding of the nature of Fabry disease and to improve the clinical management of patients with this disorder" says lead author Dr Miguel-Angel Barba-Romero from Albacete University Hospital, Spain.

"It is an international outcomes database for all patients with Fabry disease who are receiving, or are candidates for, enzyme replacement therapy with agalsidase alfa."

This study compared the data from 92 Spanish patients (41 men and 51 women) from 29 hospitals, with data from 1,453 patients from across Europe (699 men and 754 women).

Key findings included:

  • 78 of the Spanish patients were adults and 14 were children. 94% of the men, 48% of the women and 29% of the children were receiving enzyme replacement therapy with agalsidase alfa.

  • The average age of symptom onset was 20 years in the men, 24 in the women, six in the boys and eight in the girls. The average time lapse before diagnosis was 11 years in the adults, one year in the boys and 0.3 years in the girls.

  • Spanish male patients were diagnosed at an earlier age than those in the rest of Europe, but the age at diagnosis was similar in women.

  • The biggest problems among adult males were kidney problems (affecting 69%), heart problems (66%) and neurological problems (60%). In female adults it was neurological problems (42%), heart problems (33%) and corneal-related eye problems (30%).

  • Fabry disease was a major cause of end-stage kidney insufficiency at a premature age in the Spanish patients, with significant associations with ill health and death. It was also the cause of premature stroke in the Spanish patients.

  • But in general, the Spanish patients demonstrated significantly less disease-related organ issues than their European counterparts and a lower frequency of corneal disease. Further investigation is needed to see if the two are linked.

  • Spanish male patients experienced the same disease severity as their European counterparts, but the severity in Spanish women was significantly lower than women in the rest of Europe.

  • Patients in the Spanish cohort were more likely to die from infections rather than the heart problems reported in other European patients.

"Our study found that Spanish patients with Fabry Disease showed classic observable traits, but different organ involvement and cause of death from the rest of Europe" says Dr Barba-Romero. "Further research is needed to explain these differences.

"In the meantime, we hope that this study provides another 'brick-in-the-wall', helping to build our knowledge of Fabry Disease. It is important that we alert clinicians to the possibility of this rare inherited disease and reduce the long delay between symptom onset and diagnosis."


'/>"/>

Contact: Annette Whibley
Annette.wizard@gmail.com
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. 6 percent of Spanish workers have high cardiovascular risk
2. One-third of Spanish children do not wake up feeling refreshed
3. Elsevier acquires Fisterra.com, a reference solution for Spanish primary care professionals
4. Around 25 percent of health messages in Spanish text books are not based on scientific evidence
5. Spanish heart risk study challenges image of healthy Mediterranean diet and lifestyle
6. Brochures explaining new health care law to patients available free in English and Spanish
7. Spanish Oncology to establish a new standard treatment on breast cancer at early stages
8. DiabetesCare.net Goes Spanish…and French…and 50 Other Languages
9. Spanish gene expression data promise targeting of anti-angiogenesis treatment
10. LifeLinks Revolutionizes Video Interpreting, Shows Spanish Interpreting in Added Dimension-VIDEO!
11. Prescriptions Translated to Spanish Could Be Hazardous to Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... The Bank of America Charitable Foundation has awarded ... provide veterans a pathway to employment and successful careers in healthcare. On Wednesday, May ... Hallack, President and CEO of Medisend, parent organization and home of the General Myers ...
(Date:5/25/2016)... ... 25, 2016 , ... CloudLIMS, joins an elite number of companies that have ... list of 2016 by CIOReview. , In a deliberate session with the honorary industrial ... 2016 has been concluded with. The positioning is based on evaluation of CloudLIMS’ specialties ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Global Wellness Summit ... unique integrative medical wellness offerings of Europe, a continent that pioneered the medical/wellness concept ... hear from numerous pioneers in medical wellness, including Henri Chenot, Founder of the Chenot ...
(Date:5/25/2016)... ... May 25, 2016 , ... The University of San ... Health Professions. She will lead a team of more than 100 full-time faculty and ... her role as dean in late August. , Baker comes to USF from the ...
(Date:5/25/2016)... ... May 25, 2016 , ... BeniComp ... a significant spike in their clients' employee participation for their wellness initiatives. ... by implementing a high-deductible health plan with outcome-based deductible incentives. As a result, ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... , May 24, 2016 ... elkaar verbindt, zodat zij collectief patiënten kunnen behandelen, hun ... is het idee achter de nieuwe en revolutionaire MDLinking ... van de Nederlandse vaatchirurg dr. Hans Flu en oncologisch ... app, die inmiddels beschikbaar is, wordt op dinsdag 24 ...
(Date:5/23/2016)... May 23, 2016 According ... Share, Development, Growth and Demand Forecast to 2022 ... Other), by Application (Drug Discovery and Development, Proteomics, ... (Pharmaceuticals, Life Science and Biotechnology, Academic and Research ... Research, the global mass spectrometry market ...
(Date:5/23/2016)... 23, 2016 Gamida Cell, a ... of cancer and orphan genetic diseases, announced today it ... million from the Israel Innovation Authority (formerly the Office ... Economy and Industry. The mission of the Israel Innovation ... industries, including science and technology, while stimulating economic growth. ...
Breaking Medicine Technology: